Psychometric Characteristics of the Fear of Cancer Recurrence Inventory-Severity Subscale Among Korean Cancer Survivors
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Despite the importance of choosing and using a valid assessment tool for fear of cancer recurrence (FCR) for early detection and interventions, the validity of the FCR inventory has yet to be thoroughly investigated in Korea. This study explored the psychometric properties of the Fear of Cancer Recurrence Inventory-Severity (FCRI-S) subscale and assessed its applicability to cancer survivors in Korea.Methods: The survey involved 93 Korean individuals who had survived cancer. The reliability of the FCRI-S subscale was assessed using Cronbach’s α and composite reliability (CR). Confirmatory factor analysis (CFA), along with tests for discriminant and convergent validity, was conducted to evaluate the construct validity of the FCRI-S subscale.Results: The FCRI-S subscale showed excellent internal consistency (Cronbach’s α=0.88; CR=0.89). CFA showed a good factor structure for the FCRI-S subscale, and the correlations of the FCRI-S subscale with FCR-related measures (<i>r</i>=0.69 to 0.80) and other psychosocial measures (<i>r</i>=-0.23 to 0.37) confirmed both the convergent and discriminant validity of the FCRI-S subscale.Conclusions: This study confirmed the robust psychometric characteristics of the FCRI-S subscale among cancer survivors in Korea. The use of the FCRI-S subscale would be helpful for health professionals to rapidly screen FCR levels in clinical settings.
Abstract
Objectives: Despite the importance of choosing and using a valid assessment tool for fear of cancer recurrence (FCR) for early detection and interventions, the validity of the FCR inventory has yet to be thoroughly investigated in Korea. This study explored the psychometric properties of the Fear of Cancer Recurrence Inventory-Severity (FCRI-S) subscale and assessed its applicability to cancer survivors in Korea.Methods: The survey involved 93 Korean individuals who had survived cancer. The reliability of the FCRI-S subscale was assessed using Cronbach’s α and composite reliability (CR). Confirmatory factor analysis (CFA), along with tests for discriminant and convergent validity, was conducted to evaluate the construct validity of the FCRI-S subscale.Results: The FCRI-S subscale showed excellent internal consistency (Cronbach’s α=0.88; CR=0.89). CFA showed a good factor structure for the FCRI-S subscale, and the correlations of the FCRI-S subscale with FCR-related measures (<i>r</i>=0.69 to 0.80) and other psychosocial measures (<i>r</i>=-0.23 to 0.37) confirmed both the convergent and discriminant validity of the FCRI-S subscale.Conclusions: This study confirmed the robust psychometric characteristics of the FCRI-S subscale among cancer survivors in Korea. The use of the FCRI-S subscale would be helpful for health professionals to rapidly screen FCR levels in clinical settings.
참고문헌 (34)
- Johnson Vickberg SM, "Fears about breast cancer recurrence", Cancer Pract, 9(5), pp.237~243 (2001)[DOI]
- Koch L, "Fear of recurrence and disease progression in long-term(≥ 5 years)cancer survivors--a systematic review of quantitative studies", Psychooncology, 22(1), pp.1~11 (2013)[DOI]
- Savard J, "The evolution of fear of cancer recurrence during the cancer care trajectory and its relationship with cancer characteristics", J Psychosom Res, 74(4), pp.354~360 (2013)[DOI]
- Thewes B, "Prevalence and correlates of high fear of cancer recurrence in late adolescents and young adults consulting a specialist adolescent and young adult(AYA)cancer service", Support Care Cancer, 26(5), pp.1479~1487 (2018)[DOI]
- Simard S, "Fear of cancer recurrence in adult cancer survivors : a systematic review of quantitative studies", J Cancer Surviv, 7(3), pp.300~322 (2013)[DOI]
- Luigjes-Huizer YL, "What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis", Psychooncology, 31(6), pp.879~892 (2022)[DOI]
- Simard S, "Fear of Cancer Recurrence Inventory : development and initial validation of a multidimensional measure of fear of cancer recurrence", Support Care Cancer, 17(3), pp.241~251 (2009)[DOI]
- Costa DS, "Psychometric properties of the Fear of Cancer Recurrence Inventory : an item response theory approach", Psychooncology, 25(7), pp.832~838 (2016)[DOI]
- Lebel S, "Empirical validation of the English version of the Fear of Cancer Recurrence Inventory", Qual Life Res, 25(2), pp.311~321 (2016)[DOI]
- Shin J, "Validation study for the Korean version of Fear of Cancer Recurrence Inventory", J Korean Med Sci, 32(11), pp.1792~1799 (2017)[DOI]
- Simard S, "Screening and comorbidity of clinical levels of fear of cancer recurrence", J Cancer Surviv, 9(3), pp.481~491 (2015)[DOI]
- Fardell JE, "Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence", Psychooncology, 27(2), pp.492~499 (2018)[DOI]
- "2022 Chronic disease trends and issue: chronic disease fact book" (2022)[URL]
- Jung KW, "Prediction of cancer incidence and mortality in Korea, 2023", Cancer Res Treat, 55(2), pp.400~407 (2023)[DOI]
- "Five-year relative survival rate of cancer patients is 72.1% up by 6.6% in ten years" (2023)[URL]
- Stein KD, "Physical and psychological long-term and late effects of cancer", Cancer, 112(11 Suppl), pp.2577~2592 (2008)[DOI]
- Pyo J, "Unmet needs related to the quality of life of advanced cancer patients in Korea : a qualitative study", BMC Palliat Care, 20(1), pp.58~ (2021)[DOI]
- Jang BY, "Subjective health status, mental health, and cancer stigma in long-term cancer survivors after gastric surgery", Asian Oncol Nurs, 18(2), pp.86~93 (2018)
- Park SY, "The experience rate of depressive symptoms and associated factors among cancer survivors : the 2019 Korea health panel survey analyses", Ment Health Soc Work, 50(3), pp.56~76 (2022)
- Custers JA, "The Cancer Worry Scale : detecting fear of recurrence in breast cancer survivors", Cancer Nurs, 37(1), pp.E44~E50 (2014)[DOI]
- van de Wal M, "Efficacy of blended cognitive behavior therapy for high fear of recurrence in breast, prostate, and colorectal cancer survivors : the SWORD study, a randomized controlled trial", J Clin Oncol, 35(19), pp.2173~2183 (2017)[DOI]
- Mehnert A, "Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire(FoP-Q-SF)", Z Psychosom Med Psychother, 52(3), pp.274~288 (2006)
- Heinrichs N, "Cancer distress reduction with a couple-based skills training : a randomized controlled trial", Ann Behav Med, 43(2), pp.239~252 (2012)[DOI]
- Kroenke K, "The PHQ-9 : validity of a brief depression severity measure", J Gen Intern Med, 16(9), pp.606~613 (2001)[DOI]
- Han C, "Validation of the Patient Health Questionnaire-9 Korean version in the elderly population : the Ansan Geriatric study", Compr Psychiatry, 49(2), pp.218~223 (2008)[DOI]
- Sherbourne CD, "The MOS social support survey", Soc Sci Med, 32(6), pp.705~714 (1991)[DOI]
- Widhiarso W, "Estimating reliability coefficient for multidimensional measures : a pedagogical illustration", Rev Psychol, 21(2), pp.111~121 (2014)
- Ferketich S, "Focus on psychometrics. Aspects of item analysis", Res Nurs Health, 14(2), pp.165~168 (1991)[DOI]
- Borreani C, "Fear of cancer recurrence in haematological cancer patients : exploring socio-demographic, psychological, existential and disease-related factors", Support Care Cancer, 28(12), pp.5973~5982 (2020)[DOI]
- Park IH, "Impact of pain, depression, fear of cancer recurrence on sleep quality in cancer patients with chemotherapy", Health Welf, 24(3), pp.213~238 (2022)
- Coutts-Bain D, "Are fear of cancer recurrence and fear of progression equivalent constructs?", Psychooncology, 31(8), pp.1381~1389 (2022)[DOI]
- Rudy L, "The FCR-1 : initial validation of a single-item measure of fear of cancer recurrence", Psychooncology, 29(4), pp.788~795 (2020)[DOI]
- Pyo J, "Qualitative research in healthcare : necessity and characteristics", J Prev Med Public Health, 56(1), pp.12~20 (2023)[DOI]
- Han KT, "National Cancer Control Plan of the Korea : current status and the fourth plan(2021-2025)", J Prev Med Public Health, 56(3), pp.205~211 (2023)[DOI]
